Prostate Cancer

By M. Hallek. Cambridge International Law Journal, 2018

2,612 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

DCAN: Deep contour‐aware networks for object instance segmentation from histology images (2017, background): “…and Kim, 2010 ), to more sophisticated methods based n hand-crafted features derived from boundaries/contours ( Naik t al., 2008; Wienert et al., 2012 ), gradients ( Veta et al., 2011 ), aplacian-of-Gaussian ( Al-Kofahi et al., 2010 ), cytological and texural features ( Nguyen et al., 2011 ), etc.”
MicroRNAs and complex diseases: from experimental results to computational models (2019, neutral): “Great progress has been made in clinical treatment of prostate cancer, including the approval of several new and effective drugs to improve the survival of advanced prostate cancer patients [134].”
Epidemiology of Prostate Cancer (2019, background): “It is estimated that about 20% of patients with prostate cancer report a family history, which may develop not only because of shared genes but also for a similar pattern of exposure to certain environmental carcinogens and common lifestyle habits [52, 53].”